Article
Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
Pharmacogenomics - 1 Jun 2010
Balboa Emilia, Duran Goretti, Lamas Maria Jesus, Gomez-Caamaño Antonio, Celeiro-Muñoz Catuxa, Lopez Rafael, Carracedo Angel, Barros Francisco
Abstract excerpt
AIMS: The identification of predictive markers of response to chemoradiotherapy treatment remains a promising approach for patient management in order to obtain the best response with minor side effects. Initially, we investigated whether the analysis of several markers previously studied and others not yet evaluated could predict response to 5-fluorouracil- and capecitabine-based neoadjuvant treatment in locally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
